Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 20 de 288 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Hallucinations and pimavanserin (NUPLAZID), a new kind of drug for psychosis. ISMP Quarter Watch 2018:6. [Ref.ID 102509]
2. Cita con resumen
Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulé A, Szoke A, Selten J-P, Turner C, Arango C, Tamcone I, Berardt D, Tortelli A, Llorca P-M, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Murray RM, Rutten BP, Jones PB, Van Os J, Morgan C, Kirkbride JB, for the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group. Treated incidence of psychotic disorders in the multinational EU-GEI study. JAMA Psychiatry 2017:6 de diciembre. [Ref.ID 102177]
3.Tiene citas relacionadas Cita con resumen
Öngür D. Dopamine dysfunction in schizophrenia and bipolar disorder - Never the twain shall meet?. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102090]
4.Tiene citas relacionadas Cita con resumen
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A tests of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102089]
5. Cita con resumen
Nugent SM, Morasco BJ, O'Neil ME, Freeman M, Low A, Kondo K, Elven C, Zakher B, Motu'apuaka M, Paynter R, Kansagara D. The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. Ann Intern Med 2017;167:319-31. [Ref.ID 102022]
6. Cita con resumen
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic pot: not your grandfathers marijuana. Trends Pharmacol Sci 2017;38:257-76. [Ref.ID 101989]
7. Cita con resumen
Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]
8. Cita con resumen
Németh G, Laszlovsky I, Czobor P, Szalai E, Szatmári B, Harsányi J, Barabássy A, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet 2017;389:1103-13. [Ref.ID 101497]
9. Cita con resumen
Patel AN, Lee S, Andrews HF, Pelton GH, Schultz SK, Sultzer DL, Mintzer J, de la Pena D, Gupta S, Colon S, Schimming C, Levin B, Devanand DP. Prediction of relapse after discontinuation of antipsychotic treatment in Alzheimer’s disease: the role of hallucinations. Am J Psychiatry 2016:1. [Ref.ID 100993]
10. Cita con resumen
Anónimo. Drugs for bipolar disorder. Med Lett Drugs Ther 2016;58:103-6. [Ref.ID 100682]
11. Cita con resumen
Stergiakouli E, Thapar A, Smith GD. Association of acetaminophen use during pregnancy with behavioral problems in childhood. Evidence against confounding. JAMA Intern Med 2016:15 de agosto. [Ref.ID 100580]
12. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
13. Cita con resumen
Anónimo. Pimavanserin (Nuplazid) for Parkinson's disease psychosis. Med Lett Drugs Ther 2016;58:74-5. [Ref.ID 100456]
15. Cita con resumen
Patel R, Wilson R, Jackson R, Ball M, Shetty H, Broadbent M, Stewart R, McGuire P, Bhattacharyya S. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study . BMJ Open 2016;6:e009888. [Ref.ID 100279]
16.Enlace a cita original Cita con resumen
Anónimo. FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease. FDA U.S. Food and Drug Administration 2016:29 de abril. [Ref.ID 100215]
17. Cita con resumen
Aldea Perona A, García-Sáiz M, Sanz Álvarez E. Psychiatric disorders and montelukast in children: a disproportionality analysis of the VigiBase. Drug Saf 2016;39:69-78. [Ref.ID 100084]
18. Cita con resumen
Schwarz A. Still in a crib, yet being given antipsychotics. New York Times 2015:1. [Ref.ID 99735]
19. Cita con resumen
McCall C. Momentum grows for medical use of cannabis. Lancet 2015;386:1615-6. [Ref.ID 99633]
20. Cita con resumen
Montastruc F. Psichopharmacologie des révolutions?. Bulletin d'Information de Pharmacologie 2015;22:37. [Ref.ID 99555]
Seleccionar todas
 
 1 a 20 de 288 siguiente >>